Form 4: Agilon Health Executive Timothy Gertsch Reports Stock and Options Transactions
SEC Form 4 Filing
Chief Accounting Officer Timothy Gertsch reports acquisition of restricted stock units and options in Agilon Health, along with holdings of common stock.
Summary
- On April 1, 2025, Timothy Gertsch, Chief Accounting Officer of Agilon Health, reported transactions involving the company's securities.
- Gertsch acquired 61,275 shares of common stock and 96,154 options with an exercise price of $4.08.
- These options vest in three equal installments on each anniversary of April 1, 2025, and expire on April 1, 2035, subject to continued employment.
- The filing also indicates that Gertsch beneficially owns 119,035 shares of common stock, including restricted stock units.
- The restricted stock units vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment.
Sentiment
Score: 6
Explanation: Neutral sentiment. The filing is a standard disclosure of stock and option transactions. The acquisition of securities by an executive is generally viewed as a mildly positive signal, but it's not a strong indicator on its own.
Positives
- The acquisition of stock and options by a key executive could be seen as a positive sign of confidence in the company's future.
Future Outlook
The vesting schedules for the restricted stock units and options are contingent upon continued employment, suggesting an expectation of continued service by the executive.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.
Stakeholder Impact
- The transactions could have a minor positive impact on shareholder sentiment due to the executive's increased stake in the company.
Key Dates
| Date | Description |
|---|---|
| 04/01/2025 | Date of earliest transaction and vesting start date for restricted stock units and options. |
| 04/03/2025 | Date of signature for the Form 4 filing. |
| 04/01/2035 | Expiration date for the options. |
Keywords
Agilon Health, Timothy Gertsch, Form 4, Stock Options, Restricted Stock Units, Beneficial Ownership, Securities Transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.